Brief: Nectar Life Sciences Reports March Quarter Consol Loss From Continuing Operations
23/07/2021 12:53
July 23 (Reuters) - Nectar Life sciences Ltd NECT.NS :
* NECTAR LIFE SCIENCES -MARCH QUARTER CONSOL LOSS FROM
CONTINUING
OPERATIONS 409.7 MILLION VERSUS PROFIT 74.2 MILLION RUPEES YEAR
AGO
* NECTAR LIFE SCIENCES -MARCH QUARTER CONSOL REVENUE FROM
OPERATIONS 3.49 BILLION RUPEES VERSUS 5.65 BILLION RUPEES YEAR
AGO
Source text for Eikon: ID:nBSE4P7J49
Further company coverage: NECT.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nectar Lifesciences
See all newsBrief: Nectar Lifesciences To Acquire 100% Paid- Up Equity Share Capital Of Avensis Exports
Brief: Nectar Lifesciences Approves Buyback Of Shares Valued At 810 Million Rupees
India's Nectar Lifesciences jumps on plan to consider buyback of shares
Brief: Nectar Lifesciences Proposes Buyback Of Equity Shares
Brief: Nectar Lifesciences Says Secured Debt And Interest Owed By Co Fully Repaid And Settled With Banks